These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2459952)

  • 21. Immunohistochemical analysis of cutaneous malignant melanoma: comparison of S-100 protein, HMB-45 monoclonal antibody and NKI/C3 monoclonal antibody.
    Fernando SS; Johnson S; Bäte J
    Pathology; 1994 Jan; 26(1):16-9. PubMed ID: 8165017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epithelial markers in malignant melanoma. A study of primary lesions and their metastases.
    Ben-Izhak O; Stark P; Levy R; Bergman R; Lichtig C
    Am J Dermatopathol; 1994 Jun; 16(3):241-6. PubMed ID: 7524376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical evaluation of necrotic malignant melanomas.
    Nonaka D; Laser J; Tucker R; Melamed J
    Am J Clin Pathol; 2007 May; 127(5):787-91. PubMed ID: 17439838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HMB-45 detection in adenocarcinomas.
    Hancock C; Allen BC; Herrera GA
    Arch Pathol Lab Med; 1991 Sep; 115(9):886-90. PubMed ID: 1718237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical evaluation of uveal melanocytic tumors. Expression of HMB-45, S-100 protein, and neuron-specific enolase.
    Burnier MN; McLean IW; Gamel JW
    Cancer; 1991 Aug; 68(4):809-14. PubMed ID: 1855181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of immunocytochemical study in the cytologic diagnosis of melanoma: evaluation of three antibodies.
    Jing X; Michael CW; Theoharis CG
    Diagn Cytopathol; 2013 Feb; 41(2):126-30. PubMed ID: 22021247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical characterization of experimental Greene melanoma.
    Wollensak G
    Ophthalmic Res; 1992; 24(1):55-8. PubMed ID: 1608593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical studies of conjunctival nevi and melanomas.
    Jakobiec FA; Bhat P; Colby KA
    Arch Ophthalmol; 2010 Feb; 128(2):174-83. PubMed ID: 20142539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S-100 protein-negative malignant melanoma: fact or fiction? A light-microscopic and immunohistochemical study.
    Argenyi ZB; Cain C; Bromley C; Nguyen AV; Abraham AA; Kerschmann R; LeBoit PE
    Am J Dermatopathol; 1994 Jun; 16(3):233-40. PubMed ID: 7943629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HMB-45 may be a more sensitive maker than S-100 or Melan-A for immunohistochemical diagnosis of primary oral and nasal mucosal melanomas.
    Yu CH; Chen HH; Liu CM; Jeng YM; Wang JT; Wang YP; Liu BY; Sun A; Chiang CP
    J Oral Pathol Med; 2005 Oct; 34(9):540-5. PubMed ID: 16138892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melanoma-associated antigen recognized by T cells (MART-1): the advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration.
    Fetsch PA; Marincola FM; Filie A; Hijazi YM; Kleiner DE; Abati A
    Cancer; 1999 Feb; 87(1):37-42. PubMed ID: 10096358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KBA.62: a useful marker for primary and metastatic melanomas.
    Pagès C; Rochaix P; al Saati T; Valmary-Degano S; Boulinguez S; Launay F; Carle P; Lauwers F; Payoux P; Le Guellec S; Brousset P; Lamant L
    Hum Pathol; 2008 Aug; 39(8):1136-42. PubMed ID: 18495211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral melanocytic lesions: differences in expression of HMB-45 and S-100 antigens in round and spindle cells of malignant and benign lesions.
    Gazit D; Daniels TE
    J Oral Pathol Med; 1994 Feb; 23(2):60-4. PubMed ID: 8164154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unique proteins defined by monoclonal antibodies specific for human melanoma. Some potential clinical applications.
    Esclamado RM; Gown AM; Vogel AM
    Am J Surg; 1986 Oct; 152(4):376-85. PubMed ID: 3766867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SM5-1: a new monoclonal antibody which is highly sensitive and specific for melanocytic lesions.
    Trefzer U; Rietz N; Chen Y; Audring H; Herberth G; Siegel P; Reinke S; Königer P; Wu S; Ma J; Liu Y; Wang H; Sterry W; Guo Y
    Arch Dermatol Res; 2000 Dec; 292(12):583-9. PubMed ID: 11214818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
    Pluot M; Joundi A; Grosshans E
    Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is MAGE-1 expression in metastatic malignant melanomas really helpful?
    Gajjar NA; Cochran AJ; Binder SW
    Am J Surg Pathol; 2004 Jul; 28(7):883-8. PubMed ID: 15223957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S100 protein and HMB-45 negative "rhabdoid" malignant melanoma: a totally dedifferentiated malignant melanoma?
    Laskin WB; Knittel DR; Frame JN
    Am J Clin Pathol; 1995 Jun; 103(6):772-3. PubMed ID: 7785665
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of immunocytochemical techniques in canine melanoma.
    Höinghaus R; Mischke R; Hewicker-Trautwein M
    J Vet Med A Physiol Pathol Clin Med; 2002 May; 49(4):198-202. PubMed ID: 12069262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tyrosinase, melan-A, and KBA62 as markers for the immunohistochemical identification of metastatic amelanotic melanomas on paraffin sections.
    Kaufmann O; Koch S; Burghardt J; Audring H; Dietel M
    Mod Pathol; 1998 Aug; 11(8):740-6. PubMed ID: 9720502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.